A patient will not be eligible for participation in this study if any of the following criteria apply.
- Prior history of myocardial infarction (MI) in the target vessel
- Presence of acute ST Elevation Myocardial Infarction (STEMI)
- Culprit vessel of Non-ST Elevation Myocardial Infarction (NSTEMI)
- TIMI flow < Grade 3 at baseline or visible thrombus
- Prior history of coronary artery bypass grafting (CABG)
- Prior heart transplant
- Severe valvular heart disease or history of valve repair or replacement
- Prior history of PCI with stent in target vessel, or target vessel involves in-stent restenosis.
- Target coronary vessel is supplied by major collaterals or is supplying major collaterals to a CTO (chronic total occlusion)
- CTO in the target vessel
- Severe diffuse disease observed in target vessel defined as the presence of diffuse, serial gross luminal irregularities present in the majority of the coronary tree
- Presence of myocardial bridge (MB), regardless of vessel location
- Contraindication for FFR examination or administration of vasodilators
- Known LVEF ≤45%
- Target lesion involves Left Main coronary artery or ostial right coronary artery
- Known renal insufficiency (eGFR < 30 ml/kg/m^2 or serum creatinine ≥ 2.5 mg/dL) unless patient is on dialysis
- Heart Failure NYHA Class III or IV
- Subject is pregnant (For a female subject of childbearing potential, a pregnancy test must be performed within 14 days (≤14 days) prior to the index procedure per site standard test)
- Subject has or had active COVID-19 symptoms and/or a positive test result within the prior 2 months
- Participation in another clinical study of an investigational drug or device
- Presence of aneurysm in the target vessel
Imaging and Pressure Tracing Exclusion Criteria:
- Artifact in pre-PCI OCT for the target lesion or in the event of multiple target lesions, artifact in pre-PCI OCT for ALL target lesions
- Target lesion requires any preparation (including but not limited to balloon dilatation, atherectomy, etc.) prior to pre-PCI OCT and physiology measurement, or in case of multiple target lesions, ALL target lesions require-any preparation (including but not limited to balloon dilatation, atherectomy, etc.) prior to pre-PCI OCT and physiology measurement
- Severe vessel tortuosity or calcification in the target vessel such that it is unlikely that the OCT catheter can be delivered
- Target lesion not imaged by OCT or in the event of multiple target lesions, ALL target lesions not imaged by OCT
- Pressure drift of > 0.03; i.e. Pd and Pa ratio value < 0.97 or > 1.03, unless physiology measurements are repeated after re-equalization
- Target lesion or significant CAD beyond 60mm from coronary ostium; i.e. not able to clearly image and capture all disease segment with OCT in 1 run
- Incorrectly done or unsuccessful catheter purge and/or contrast flush
- Presence of plaque rupture and/or intravascular hematoma in target vessel (visual % diameter stenosis ≥ 40%)
- Inability to receive intracoronary nitroglycerin prior to OCT or FFR
- Use of flush media other than radiographic contrast